Judge Corporate-Funded Studies on Their Merits


During the past decade, the drumbeat against corporate-funded science has sounded in major journals, books and the news media. The backlash against this research has seeped into the judicial system, appearing to influence judges and juries to believe that "buying science" is a corporate phenomenon. Perhaps no greater example of this trend is the U.S. Supreme Court decision in Exxon Shipping Co. v. Baker, 554 U.S. 471 (2008), in which Justice David Souter — writing for a 5-3 majority — declined to rely on a body of jury research examining the predictability of punitive damage awards, simply because the "research was funded in part by Exxon," the corporate defendant. The criticisms of corporate-funded scientific research, specifically in litigation, will likely continue affecting corporations and various industries for decades. From recently instituted climate-change litigation (specifically Connecticut v. American Electric Power Co., 406 F. Supp. 2d 265 (S.D.N.Y. 2005) and Comer v. Murphy Oil USA, 2009 WL 3321493, 17 (5th Cir. Oct. 16, 2009)) to pharmaceutical, mass-tort and other products liability cases, as well as potential litigation resulting from the 2010 BP Gulf oil disaster, corporations may continue to face a no-win situation when relying on self-funded scientific research. If they invest in scientific research that may answer questions raised in litigation, a court may ignore the findings because of their financial support. If they do not make such investments, they may then face criticism for failing to adequately evaluate the hazards and consequences resulting from a product, drug or business operation.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Business Organization Updates, Civil Procedure Updates, Finance & Banking Updates, Products Liability Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Duane Morris LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »